[HTML][HTML] Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020

A Nabil, K Uto, MM Elshemy, R Soliman… - EXCLI …, 2020 - ncbi.nlm.nih.gov
Coronaviruses are a group of enveloped viruses with non-segmented, single-stranded, and
positive-sense RNA genomes. In December 2019, an outbreak of coronavirus disease 2019 …

An updated review on COVID-19

MA Ebada, A Wadaa-Allah, E Bahbah… - … Formerly Current Drug …, 2021 - ingentaconnect.com
Coronavirus Disease (COVID-19) pandemic has affected more than seven million
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …

COVID-19: Diagnostics, therapeutic advances, and vaccine development

S Majid, MS Khan, S Rashid, A Niyaz, R Farooq… - Current Clinical …, 2021 - Springer
Abstract Purpose of Review Human race is currently facing the wrath of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly transmittable and pathogenic …

[HTML][HTML] Approaches towards fighting the COVID‑19 pandemic

SC Tsai, CC Lu, DT Bau, YJ Chiu… - International …, 2021 - spandidos-publications.com
Abstract The coronavirus disease 2019 (COVID‑19) outbreak, which has caused> 46
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …

[HTML][HTML] Medical management of COVID-19: evidence and experience

S Bose, S Adapa, NR Aeddula, S Roy… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …

A journey from SARS-CoV-2 to COVID-19 and beyond: a comprehensive insight of epidemiology, diagnosis, pathogenesis, and overview of the progress into its …

MH Shoaib, FR Ahmed, M Sikandar… - Frontiers in …, 2021 - frontiersin.org
The 2019 novel coronavirus (2019-nCoV), commonly known as severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), was first …

Review of registered clinical trials for the treatment of COVID‐19

F Babaei, M Mirzababaei, M Nassiri‐Asl… - Drug Development …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a viral disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …

[PDF][PDF] Coronaviruses and the associated potential therapeutics for the viral infections

S Wang, Y Zhang, S Liu, H Peng, V Mackey… - J Infect Dis …, 2020 - researchgate.net
Coronaviruses (CoVs), named after the crown-like spikes on their surfaces, belong to the
RNA virus family Coronaviridae. Coronaviruses are enveloped RNA viruses with a linear …

[HTML][HTML] Treatment options for COVID-19: The reality and challenges

SS Jean, PI Lee, PR Hsueh - Journal of microbiology, immunology and …, 2020 - Elsevier
An outbreak related to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first reported in Wuhan, China in December 2019. An extremely high potential for …

[HTML][HTML] Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

KL Hon, KKY Leung, AKC Leung, SY Qian… - Drugs in …, 2020 - ncbi.nlm.nih.gov
Many viral respiratory infections can cause severe acute respiratory symptoms leading to
mortality and morbidity. In the spring of 2003, the severe acute respiratory syndrome (SARS) …